Clinical Trial Update: Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating radiation therapy plus gadolinium texaphyrin (motexafin gadolinium) in patients with unresectable pancreatic cancer. The study has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Xcytrin (motexafin gadolinium)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED